Novartis is scolded by U.K. trade group for the third time this year over Entresto marketing
For the third time this year, Novartis has been rebuked by a U.K. trade group for misleading promotional efforts for its biggest-selling drug.
For the third time this year, Novartis has been rebuked by a U.K. trade group for misleading promotional efforts for its biggest-selling drug.
A nonprofit group is doing deals in Brazil and India to make low-cost CAR-T cell therapies widely available.
At least 224 diabetes patients have been harmed by a software error causing their insulin pumps to spontaneously shut down, the FDA said Wednesday.
Google on Wednesday unveiled an AI tool capable of predicting the structure and interaction of a vast universe of biomolecules.
Two congenitally deaf children can hear after being treated with a gene therapy, according to new data from an ongoing clinical trial.
The FDA nod means trial sponsors can use Apple Watch’s A-fib history as a secondary endpoint in trials without having to do additional work.
New ways of identifying and testing therapies, a more precise understanding of disease, and a renewed sense of urgency could help speed up drug development.
The federal government will provide livestock farms with money to bolster protective measures and testing for the avian flu virus spreading among dairy cows, officials…
Endo “was one of the worst actors in the opioid crisis” said Andrew Kolodny of the Opioid Policy Research Collaborative at Brandeis University.
“We’ve sort of anthropomorphized AI and said it has to be a thing that’s going to replace a human. Why are we not reenvisioning that…
The authors argue that the APOE4 gene variant plays an even more important role than scientists had realized and causes a distinct form of Alzheimer’s.